-• UNIVERSITY OF IBADAN LIBRARY 'CHEMOPREVENTIVES: UNTAPPED GENII THAT COMPROMISE THE SCIENCE OF THE "KILLERS" An inaugural lecture delivered at the University of Ibadan on Thursday, 03 March, 2016 By EBENEZER OLATUNDE FAROMBI Professor of Biochemistry and Molecular Toxicology Faculty of Basic Medical Sciences University of Ibadan Ibadan, Nigeria UNIVERSITY OF IBADAN UNIVERSITY OF IBADAN LIBRARY Ibadan University Press Publishing House University of Ibadan Ibadan, Nigeria. © University of Ibadan, 2016 Ibadan, Nigeria First Published 2016 All Rights Reserved ISBN: 978 - 978 - 952 - 814-1 Printed by: Ibadan University Printery UNIVERSITY OF IBADAN LIBRARY The Vice-Chancellor, Deputy Vice-Chancellor (Admini- stration), Deputy Vice-Chancellor (Academic), The Registrar and other Principal Officers, Provost of the College of Medicine, Dean of the Faculty of Basic Medical Sciences, Dean of the Postgraduate School, Deans of other Faculties and of Students, Distinguished Ladies and Gentlemen. As I give this lecture on behalf of the Faculty of Basic Medical Sciences of the College of Medicine, I exalt, glorify and magnify the Almighty God, the King of kings, the Lord of lords; the One who was, who is and who is to come, the Giver and Preserver of life, the Source of wisdom and knowledge and whose inspiration gives men understanding. This lecture is coming up about ten years since I was promoted to the grade of a Professor of Biochemistry of this University. I am grateful to the Dean of our Faculty for giving me the opportunity to stand on this podium today to address the Vice-Chancellor and this distinguished audience within and outside the discipline of Biochemistry. The first inaugural lecture from the Department of Biochemistry titled 'Power House of the Living Cell' was delivered by Professor Enitan Abisogun Bababunmi in 1982. The second lecture was delivered by my academic father, Professor Godwin Onyenoro Emerole, with the title 'Xenobiotics in Biochemical and Cellular Dysfunction'. Ten years later, Professor Anthony Osaigbovo Uwaifo delivered the third lecture titled, 'Cancer: A consequence of Cellular Break-down of Law and Order'. Professor Olufunso Olabode Olorunsogo delivered the fourth lecture in 2010 with the title 'From Power House to Pumps: Memoirs of a Mitochondriac'. Today with all sense of humility, I present the 5th inaugural lecture titled, "Chemopreventives: Untapped genii that compromise the science of the "Killers". Introduction My journey into Biochemistry and subsequently making academic a career was by divine arrangement. I graduated as 1 UNIVERSITY OF IBADAN LIBRARY the best student at both the BSc and MSc levels In Biochemistry and as such had the option in the 80's of working in companies and industries with better pay as against my initial salary of less than W500 per month when I joined the services of this University. I recall that the Head of Department at that time, Professor Anthony Uwaifo, while descending the staircase of the old Biochemistry building, met me around 5 pm in the month of December 1989 and said, "Farombi, I'm going to recommend you for a job in the Department". I replied and said, "Sir, I did not apply for any job". He told me that the Departmental Academic Board just had a meeting and I was adjudged the best MSc student and that it is the tradition of the Department to always retain the best. I was thrilled and speechless about this comment. After sleeping over the information, it was impressed on me by the Spirit to take the job. I stand tall before you today to the glory of God Almighty, I have no iota of regret for venturing into the discipline of Biochemistry and making academics a career. As stated in the Holy Bible in Jeremiah 10: 23, "The way of a man is not in himself, it is not in man that walk to direct his steps". Mr. Vice-Chancellor Sir, since joining the Department twenty six years ago I have supervised and trained one hundred and fifty MSc students, nineteen PhD students and several BSc students. Two of my former students are Professors, another is an Associate Professor and many others occupy senior positions in various industries, research institutes and oil companies across the country and abroad. The Department of Biochemistry, University of Thadan has been very outstanding in teaching, research and admini- stration since its' inception. Being a service Department, it occupies a prominent position in the College of Medicine and the University. The research capacity of the Department was further enhanced in 1979 when four research sections were created namely Membrane Biochemistry, Cancer Research, Nutritional and Industrial Biochemistry and Drug Metabolism and Toxicology Units. Over the years these four Units have advanced research in their specialized areas. I have the 2 UNIVERSITY OF IBADAN LIBRARY opportunity of being trained by one of the older generation and a foremost Biochemist in the person of Professor Godwin Emerole in the area of Drug Metabolism and Toxicology. Today, I shall present some aspects of research conducted in this field. Toxicology of Therapeutic Drugs Plasmodium malaria, caused by Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale or Plasmodium malariae is a serious disease affecting most of tropical Africa. About 3.3 billion people are at risk of malaria worldwide and about 215 million cases occur yearly with an estimated mortality of about 1 million (WHO 2013). Today, the efforts directed at controlling malaria are met with a series of daunting setbacks. While antimalarial drugs are becoming increasingly resistant to emerging strains of Plasmodium, vaccines so far developed have not been able to confer sufficient protection against the parasite. Nonetheless, chemotherapy, which is relatively cheap and accessible to most patients, still remains the most reliable remedy against the infection. Amodiaquine and Chloroquine which belong to the class of 4-amino quinolines are widely used in the malaria endemic tropical regions of the world in the prophylaxis and treatment of malaria. Chloroquine in particular has wide therapeutic properties including analgesic, antipyretic and anti- inflammatory activities. These properties endeared chloro- quine as the drug of choice to a number of countries in the tropics where malaria is endemic. The current use of combinations of drugs to eradicate infection has raised serious concerns about the possibility of drug-drug interaction, which may potentiate toxicity. This development, therefore, necessitates judicious and efficient management of the few available antimalarial drugs. Both chloroquine and amodiaquine have still not left Nigeria market for chemosuppression and radical cure of malaria because they are cheap, rapidly effective and readily 3 UNIVERSITY OF IBADAN LIBRARY available. Mefloquine, a quinoline methanol and halofantrine (HF), a phenanthrene methanol are two antimalarials introduced into the market after chloroquine and amodiaquine. Both have advantageous pharmacologic actions that require fewer doses thereby enhancing compliance. Due to the multi drug resistant strains of Plasmodium falciparum that have emerged worldwide in recent times, all these antimalarial drugs have lost their potency and ability to radically cure malaria especially when used singly. Therefore, WHO recommended the use of Artemisinin Combination Therapy (ACT) as first line drugs for treating malaria even though some resistance to these drugs have also been reported in certain parts of the world especially South East Asia. The antimalarials are known to affect a wide range of biochemical processes in the living cell. Our research unit in Biochemistry Department, named Drug Metabolism and Toxicology Research Laboratories, which recently metamorphosed to Molecular Drug Metabolism and Toxicology Research Laboratories, is reputed for its unique research and contribution to the Toxicology of Therapeutic Drugs. Following the earlier report of Emerole and Thabrew in 1983 on the interference of Chloroquine on drug metabolism, we investigated the changes in microsomal drug oxidizing enzymes, and microsomal lipids in rats treated with therapeutic doses of three structurally-related antimalarial drugs, Amodiaquine, Halofantrine and Mefloquine. We reported that these drugs inhibited the selected phase 1 drug oxidizing enzymes aniline hydroxylase, p-nitroanisole O-demethylase and pentoxyresorufin O-dealkylase (fig. 1) and interfered with microsomal lipids to varying extents, and this was related to the structural differences in the compounds (Farombi et al. 2000a). 4 UNIVERSITY OF IBADAN LIBRARY PROD ** CT MQ CT MQ CT MQ AQ HF AQ HF AQ HF Fig. 1: Effects of therapeutic doses of antimalarial drugs on the activities , of rat microsomal aniline hydroxylase, p-nitroanisole O-demethylase and pentoxyresorufin O-dealkylase activities. * Significantly different from control, P .!: 800 :·fii ""2 un:::: ~ •c 600 ili~ 'f•i l 400 <••II !! ~ 200 c•.•. 0 Blood Liver Testes Fig. 6: Relative percentage change in metal concentrations in the tissues of rats exposed to bonny light crude oil. Source: Adedara et al. 2013. (A) • __ - StAR, 46 kDa (8) ~ _ ASP,30kDa 1 Actin,42kDa .-. ~ ~ Actin, 42 kDa 1.2 1.2 c 1.0 .Q 'e" [~ 0.8 ~::J c -ae; > "e - 0.6 c.-€ .~~ 0.4 S £ 0.2 0.0 Control 200mglkg 800mglkg Control 200mglkg 800mglkg Fig. 7: Effects of Bl.Ct) on StAR (A) and ABP (B) expression in adult male rats (n.7). Data are expressed as mean ± SD. *Values differ significantly from control (p<0.05). Source: Adedara et al. 2014a. 16 UNIVERSITY OF IBADAN LIBRARY 3p -HSD 1,6. to llh 24h 72h Oh 6h i?-h Un 7211 Time after treatment with BLeD Time after treatment with BLCD Fig. 8: (a) Effect of BLCO on the activity of 313-HSD in the testis of adult rats over different time points. (rr=l) per time point. *; statistical significance at p H ~ ,. cc,c'f.S H,C'S""''-v''''-'''' N o• SIII!JIl!I'8IlIIIII lyoopellf Fig. 13: Representative chemopreventive phytochemicais and dietary sources. Source: Surh 2003. Mechanisms of Chemoprevention Chemoprevention is a term that was originally applied to cancer development. However, in the last two decades chemoprevention has been extended to other chronic degenerative diseases. For the purpose of this lecture, I shall explain the mechanism of chemoprevention by focusing on 29 UNIVERSITY OF IBADAN LIBRARY cancer. Carcinogenesis is generally recognized as a multistep process in which distinct molecular and cellular alterations occur. From the study of experimentally-induced carcino- genesis in rodents, tumour development is considered to consist of several separate, but closely linked, stages- tumour initiation, promotion and progression (fig. 14). Initiation is a rapid and irreversible process that involves a chain of extracellular and intracellular events. These include the initial uptake of or exposure to a carcinogenic agent, its distribution and transport to organs and tissues where metabolic activation and detoxification can occur, and the covalent interaction of reactive species with target-cell DNA, leading to genotoxic damage. In contrast to initiation, tumour promotion is considered to be a relatively lengthy and reversible processes in which actively proliferating preneo- plastic cells accumulate. Progression, the final stage of neoplastic transformation, involves the growth of a tumour with invasive and metastatic potential. Mr. Vice-Chancellor, my involvement in chemo- prevention dates back to 1989 during my PhD training in Biochemistry Department as a paradigm shift from the research on environmental toxins and carcinogens focused on by my mentors in the Department. In this connection, my research activities in the last 25 years have focused on the use of naturally-occurring agents (dietary agents and indigenous plant-based phytochemicals) with antioxidant and anti- inflammatory properties to prevent or delay the onset of several diseases such as cardiovascular disorders, reproductive dysfunction, cancer (gastrointestinal, prostate, liver), and neurological disorders, as well as understanding their molecular mechanisms with emphasis on signal transduction network. This area of research has enabled me to interact and collaborate with world-class experts in the field in countries spanning 4 continents of the world. 30 UNIVERSITY OF IBADAN LIBRARY Pro--carcincgoo A.... Detoxification U .' 0c3:-!<1.-0<) ---- ..,.••I8ecrntibr) I @1~=:,..,.~, ~~ @~1orrmJ llnitiatioo . Pmooq:>. IasIic{1-2 days) C'==»"",>'""·' 431 469- 3lJ 341- [ ~ .s eoc• J9J c: m- .Q .Q !l '".. .~.Q .Q. 71 84- .4lJ--t-----'------.--------.1 .44--t---L-------. --------. 1 1 OO:{lO 04:00 08:00 00:00 06:00 n:ol Tim, [••• :,,] Ti••• [•••• :••] Fig. 20: HPLC chromatogram of isolated 6-gingerol from rhizomes of Zingiber officinale (A). HPLC chromatogram of standard 6-gingerol (B). This figure is available in colour online at wileyonlinelibrary. com/journal/ptr. Source: Ajayi et al. 2015. 46 UNIVERSITY OF IBADAN LIBRARY Using Dextran sulphate sodium-induced colitis experimental model known to mimic the pathological features of human colitis, we showed that 6-Gingerol suppressed the induction of colonic oxidative damage and circulating concentrations of pro-inflammatory cytokines in mice (table 2) as well as preneoplastic lesion in distal colon of mice (fig. 21) (Ajayi et al. 2015). Furthermore, in our chronic ulcerative colitis model, using sulfasalazine (anti-colitis drug) as positive control, 6-gingerol reversed the clinical features of chronic colitis ranging from diarrhea, shortening of the colon to rectal bleeding. Using immunohistochemical technique, we further showed that 6-gingerol attenuated markers of oxidative and nitrosative stress and abrogated a panel of pro- inflammatory genes and certain transcription factors expressed in chronic ulcerative colitis. Our preliminary data shows. its effect on colon cancer and experiments are ongoing in my laboratory to establish the veracity of this claim. In totality, these studies qualify 6-gingerol as anti-colitis drug and a lead compound in the possible management of human colon cancer. Table 2: Effects of 6-gingerol on Levels of Interleukin-Ijl, Tumor Necrosis Factor Alpha, Nitric Oxide Concentration, and . Myeloperoxidase Activity in DSS-exposed Mice Control 6·GRalone DSSalone DSS "6·GR1 DSSt6-GR2 DSS+6-GR3 1l·1~ 91.21±4.06 90.32±5.08 118.7±4.21' 92.57±4.08b 91.14±5.0a" 88.89±4.W' Ttfll 19.24±2.51 19.46f2.27 34.71 ±2.25' 18.84± 2.07b 19.6±2.07b 21.H2.0'f NO 2.32±O.25 2.36tO.28 3.78±O.23' 2.4B±O.45b 2.40±O.3gl> 2.45tO.2t MPO 1.4!hO.16 1.45iO.35 2.11:0.21' 1.52±O.34b 1.46±O.3i' 1.51iO.2'f IL-IP, interleukin-If (pg/ml.); TNF-a, tumor necrosis factor alpha (pglrnL); NO, nitric oxide (units/mg protein); MPO, myeloperoxidase (units/mg protein); DSS, dextran sulphate sodium. 6-GRl, 6-GR2, and 6- GR3 denote 50, 100, and 200 mglkg of 6-gingerol, respectively. Each bar represents mean ± SD of seven mice. 'Values differ significantly from control (p<0.05). bValues differ significantly from DSS group (p<0.05). Source: Ajayi et al. 2015. 47 UNIVERSITY OF IBADAN LIBRARY Fig. 21: Effects of 6-gingerol on DSS-induced preneoplastic lesion in . mice distal colon. Control and 6-gingerol alone (6-GR) showing normal architecture without suspicious focus. Colons of mice treated with DSS alone have enlarged ulceration with several aberrant crypt foci. Dextran sulphate sodium-treated mice administered with 6- gingerol at 50 mg/kg (6-GRl) and 100 mg/kg (6-GR2) showing normal architecture. Dextran sulphate sodium mice administered with 6-gingerol at 200 mg/kg (6-GR3) showing normal histological structure but with mild ulceration and a very few aberrant foci (red arrow). Original magnification of 160X. Source: Ajayi et al. 2015. Garcinia kola Heckel (Guttiferae) Another interesting chemopeventive and our favourite in Biochemistry Department is Garcinia kola, a tropical flowering plant found in western and central Africa, which produces large, orange fruits and brown, nut-like seeds embedded in an orange-coloured pulp. It is popularly known as bitter kola because of its bitter taste. It is called various names in different parts of Nigeria: Orogbo (Yoruba), Edun (Edo), Namiji ngooro (Hausa), aku ilu, ugugolu (Igbo). Bitter kola plays pivotal role in traditional hospitality and ceremony. For instance bitter kola and other components like sugar cane, kolanut and honey are usually presented during naming ceremony of babies and the officiating elder uses the 48 UNIVERSITY OF IBADAN LIBRARY seed to pray for the child, with the believe that properties of longevity and pleasant living will be conferred on the baby. The elders after chewing the seed pray thus "Orogbo 1'0 ni kio gbo, obi nii bi ibi danu, nire nire laa soro ataare, ladun- ladun la aba ile oniyo, adun ni toyin, adun ni tireke" meaning bitter kola (orogbo) says you should grow to old age, kolanut (Obi) wards away evil, table salt (lyo) is always found with sweetness, honey is renowned for sweetness, sugar cane is renowned for sweetness too. Apart from the cultural use of bitter kola, it plays a very important role in African ethno-medicine. The seed is employed as a general tonic, and is believed to ' cure impotence. Traditionally, the seeds are used in the treatment of inflammatory disorders and liver disease. For instance, extracts of the seeds led to remarkable improvement of liver function in patients with chronic hepatitis and cholangitis after treatment for ·14 days at a Nigerian herbal home (Iwu 1982). The seeds are used medicinally to treat parasitic, microbial, and viral infections as well as treatment of bronchitis, throat infections, chest colds, and coughs. Some of these claims have been verified by experimental findings. For instance Mr. Ifeoluwa Awogbindin, one of my PhD students, under the mentoring of myself and Professor David Olaleye of our Virology Department, demonstrated that bioflavonoid fraction from Garcinia kola protected BALB/c mice against influenza AlPerth/H3N2/16/09 (PrIH3N2) virus infection (Awogbindin, Olaleye and Farombi 2015). This study indicates that this fraction is effective for delaying the development of clinical symptoms of influenza virus through a mechanism unrelated to those deployed by the existing anti- influenza drugs but closely associated to its antioxidant and immunomodulatory properties. Phytochemical studies on Garcinia kola revealed the presence of complex mixtures of phenolic compound triter- penes and benzophenones. Subsequently, Kolaviron (biflavonoid complex containing GB 1, GB2 and kola- flavanone), a deffated fraction of alcoholic extract of Garcinia kola seeds was isolated (Iwu 1985) (fig. 22). Other 49 UNIVERSITY OF IBADAN LIBRARY researchers have isolated some other compounds from bitter kola. For example, one of my PhD students Dr. Ademola Oyagbemi, while collaborating with-my friend late Professor Johan Esteryhyse of the Cape Peninsular University of Technology, .Cape Town South Africa- isolated and characterized for the first time Squalene, a novel antioxidant, anticancer and cholesterol lowering phytochemical and Rugulosin which has antibiotic and antimycotic properties and acts asmv-1 i-ntegraseinhibitor. Mr. Vice-Chancellor, our interest in Garcinia kola research, especially the characterized bioflavonoid termed Kolaviron, dates back to ·23 years in Biochemistry Department. The interest in the research was facilitated by my mentor and PhD Supervisor, Professor Godwin Emerole. Today, we have graduated over 50 MSc students, 6 PhD students and currently another PhD student is on the project. Under the training of Professor Emerole and my humble self, Dr. O.A. Adaramoye whose promotion to the grade of Reader was announced a few days ago, was the first PhD student on Garcinia kola. We have also collaborated with world experts on chemoprevention on the project in countries spanning 4 continents of the world. In other words, we have taken research on this wonderful seed beyond the shores of this country. Our systematic and mechanistic experimental findings at the cellular and molecular levels have lent credence to the therapeutic value of this seed earlier alluded to by traditional elders. Although some do not know the value of this seed and therefore it has remained untapped as a novel chemopreventive and therapeutic agent, just like the Nigerian Juju musician, King Sunny Ade in 1973 released a musical album on this seed and said "Ki Ian fani Orogbo, Kilan fani Orogbo, Ohun ta pa ti 0 lawe, eyi ta je to tun koro, Kilan fani Orogbo----". It was later in 1977, I guess elders who understood the real value of bitter kola corrected him and he released another album and sang thus: "Mojorogbo, Kiohun mi le gbo, mo jogede, ki ohun mi le de, mo je kukundu ku olohun areree=", 50 UNIVERSITY OF IBADAN LIBRARY RI R2 R3 R4 GBI OH H OH H GBl OH H. OH OH Kolanavanone OH H OCH, OR KOLAVIRON FROM GARCINIA KOLA Fig. 22: Garcinia kola and isolated bioflavonoid termed Kolaviron. I shall now summarize some of our humble contributions to knowledge on Garcinia kola and its isolated bioflavonoid, Kolaviron, as novel chemopreventive agent. Kolaviron as Liver Chemopreventive Agent Garcinia kola seeds and seed extracts have been shown to be of benefit to human health, and relevant in the management and chemoprevention of life-threatening diseases. The effects range from antidiabetic, immunomodulatory, antiviral, anti- inflammatory, and antioxidant activities to strong hepatoprotective properties. Kolaviron and other isolates of Garcinia kola seeds were shown to protect against CCI4- induced liver injury, reduce significantly CCl4-induced increases in serum aminotransferases and sorbitol dehydro- genases, and protect against CCl4-mediated liver damage by modulating the cholesterol:phospholipid ratio as well as the toxic onslaught imposed on liver microsomal marker enzymes (Farombi 2000). Kolaviron given orally to rats prior to challenge with 2-acetylaminofluorene reversed its effects on ornithine carbamyltransferase and other biochemical indices of hepatic damage (Farombi et al. 2000). The protective effect of kolaviron was comparable to the effect of butylated hydroxylanisole, indicating that kolaviron may act 51 UNIVERSITY OF IBADAN LIBRARY as chain-breaking in vivo antioxidant. Furthermore, purified fractions from Garcinia kola elicited hepatoprotective properties in the same model of CCLJ-mediatedliver damage (Adaramoye et al. 2008). Of particular interest is the remarkable effect 'Ofkolaviron on Aflatoxin Bt (AFB.)-induced liver damage. AFBr- a potent hepatotoxic and hepatocarcinogenic agent, is produced by the mould Aspergillus flavus, which contaminates cereal grains and nuts in tropical regions of the world such. as Nigeria. AFB. and hepatitis B have been implicated in the aetiology of hepatocellular carcinoma, which has one of the poorest 5-year survival rates (Groopman et al, 1992) and accounts for 15% of total cancer mortality. We demonstrated the chemopreventive effect of kolaviron against the hepatic oxidative damage (fig. 23) and genotoxicity (fig. 24) induced by APR. in rats (Farombi et al. 2(05) by mechanisms involving induction of phase 2 xenobiotic metabolizing enzymes capable of detoxifying toxic aflatoxin metabolites. We showed also that Kolaviron protected against Dimethyl nitrosamine (DMN)-mediated liver toxicity and histological changes in rats (fig. 25) (Farombi et al. 20(9). 52 UNIVERSITY OF IBADAN LIBRARY 60r • 17 -:s 1400S * • 6 e~1200 ~ I:twtl r1000 "C !800 ·'.;6600 :!v 400 ~ ::9v 2000 - 0 CTRl KV Fig. 23: Effects of kolaviron, vitamins C and E on (A) the activities of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gamma glutamyltransferase (y-GT), (B) malondialdehyde (MDA) and lipid hydroperoxide (LHP) of rats treated with aflatoxin B. (AFB.). *P- 70 ~:E *60 ** ** ~i 50 ** ***~ ~ 40· ~:i .~a3020 0"i 10 ~- 0 Fig. 28: Inhibitory effect of kolaviron and curcumin on DMN-induced COX-2 expression in rat liver. Quantifications of COX-2 (A) and iNOS (B) immunoblots were normalized to that of actin followed by statistical analysis of relative image density in comparison to control. Lane 1, control; lane 2, DMN-treated; lane 3, kolaviron (100 mg/kg) plus DMN; lane 4, kolaviron (200 mg/kg) plus DMN, lane 5, curcumin (200 mg/kg) plus DMN. (*P